Recent Headlines
Within Biotechnology
Eagle Biosciences Introduces New Intact FGF23 ELISA Assay Kit
Eagle Biosciences, Inc. is proud to announce the launch of a new assay, MedFrontier FGF23 (Human Intact FGF23) ELISA Assay Kit. MedFrontier FGF23 (Human Intact FGF23) ELISA Assay Kit utilizes a simple 96 well sandwich ELISA procedure that measures ONLY the full-length active form (intact form) in under three hours. - January 26, 2018 - Eagle Biosciences, Inc.
Wake Research Welcomes Christine Heironimus as New Director of Business Development and Strategic Network Acceleration
Wake Research Welcomes Christine Heironimus as New Director of Business Development and Strategic Network Acceleration. - January 25, 2018 - Wake Research Associates
InBody Will Provide Free Body Composition Tests at ASPEN 2018 Nutrition Science & Practice Conference in Las Vegas, Nevada
Attendees will also receive a free consultation at InBody’s booth (#200) in Caesar’s Palace from January 23rd to January 24th. - January 24, 2018 - InBody
What’s Better Than Winning a Mobile Website Design Award? Winning 2 Mobile Website Design Awards!
Arteric.com named Best Advertising Mobile Website and Best Interactive Services Mobile Website. - January 17, 2018 - Arteric
European Commission Approves Endoceutics’ Drug IntrarosaTM for the Treatment of Vulvar and Vaginal Atrophy in Postmenopausal Women
The European Commission has adopted the following on 8 January 2018: Adoption of Commission Implementing Decision granting marketing authorisation under Regulation (EC) No 726/2004 of the European Parliament and of the Council for "Intrarosa - Prasterone," a medicinal product for human... - January 15, 2018 - Endoceutics
DrugCendR Inc. to Present Phase I Plans on 2 Occasions During the JP Morgan Healthcare Conference in San Francisco Next Week
As DrugCendR is now preparing to transition from a preclinical to a clinical-stage company, the company will present details on their Phase I–ready lead compound CEND-1 – a highly innovative molecular mimicry agent that is able to activate a drug transport mechanism specifically in solid tumors. To date, there are more than 100 studies using DrugCendR’s proprietary technology, providing an unprecedented amount of preclinical validation / proof-of-concept. - January 04, 2018 - DrugCendR
SARI Announced It Has Entered Into an Agreement to Acquire the 90% Interests in NMS Group
SARI is a Chinese market-leader biotech investment company. - December 30, 2017 - NMS Group
NINDS Awards $150,000 Grant to NuvOx Pharma for Development of Field-Ready Syringe for Oxygen Delivery Drug
NuvOx Pharma, a clinical stage biotechnology company, has received a Phase I SBIR grant for $150,000 from the National Institutes of Health, specifically the National Institute of Neurological Diseases and Stroke (NINDS). This grant will fund development of a novel syringe sonication device that... - December 30, 2017 - NuvOx Pharma
SCOTS Eye Stem Cell Study Reports Vision Recovery in Optic Nerve Stroke (NAION); Other Blindness
Stem Cell Ophthalmology Treatment Study in Florida makes progress treating “untreatable” optic nerve and retinal conditions with publication of positive outcomes. - December 29, 2017 - MD Stem Cells
AdvantaPure(R) Introduces Sterile, Single-Use, Molded Filling Assemblies for Aseptic Fill and Finish Applications
Single-Use filling assemblies for fill and finish applications in biopharmaceutical and pharmaceutical processing are now available from AdvantaPure. They feature molded connections for seamless fluid flow. Supplied sterilized and ready to install, the assemblies are manufactured with tubing, bags, filters, sterile connectors, filling needles and other accessories specified by the customer. Two tubing materials are offered. - December 21, 2017 - AdvantaPure
cliexa® Partners with Preventative Technology Solutions on Risk Assessment Solutions; New Product Will Help Physicians Address Behavioral Health Risks in Adolescents
cliexa, Inc., developer of a mobile platform for chronic disease management, announces today a collaboration with Preventative Technology Solutions, Inc., (PTSI), provider of medical assessment applications and mHealth prevention services for adolescents and young adults. cliexa has licensed PTSI... - December 19, 2017 - cliexa
Targeted Hyperthermia Treatment Accepted for Full Characterization at the Frederick National Laboratory for Cancer Research
Siva Therapeutics in partnership with NanoHybrids have teamed to develop and manufacture gold nanoparticles for treating cancer with hyperthermia. The nanoparticle treatment was submitted to the Frederick National Laboratory for Cancer Research and has passed the first stages in the Nanotechnology Characterization Laboratory, which helps pave the way for regulatory review of nanotechnologies intended for cancer therapies and diagnostics. - December 15, 2017 - NanoHybrids
NanoHybrids Inc. Awarded NIH Grant to Advance Nanoparticle Enabled Photodynamic Therapy for Oral Cancer
NanoHybrids Inc. has been awarded $300,000 by the National Cancer Institute of the National Institutes of Health (NIH) through the Small Business Technology Transfer (STTR) program to enhance the therapeutic efficacy of photodynamic therapy (PDT) in oral cancers. - December 15, 2017 - NanoHybrids
BioStat Solutions, Inc. (BSSI) Announces New Director of Clinical Operations – Eloi Kpamegan, Ph.D.
BioStat Solutions, Inc. today announced that Eloi Kpamegan, Ph.D. has accepted the position of Director, Clinical Operations. - December 14, 2017 - BioStat Solutions, Inc.
Qualitative Identification of Synthetic Cannabinoids Using Liquid Chromatography Quadrupole Time-of-Flight Mass Spectrometry (LC-QTOF/MS)
A presentation at the Southwestern Association of Toxicologists November 2017 scientific meeting in San Antonio, Texas highlighted the utility of Cayman’s Synthetic Cannabinoid Screening Library. This library is comprised of more than 350 synthetic cannabinoid standards, including parent... - December 14, 2017 - Cayman Chemical Company
GeneFluidics Announces CE-IVD Marking of UtiMax™ Uropathogen Identification (ID) and Antimicrobial Susceptibility Testing (AST)
GeneFluidics, a molecular diagnostics company specializing in the development of diagnostics solutions for infectious diseases, today announced CE marking for UtiMax™ under the Directive 98/79/EC on in vitro diagnostic medical devices. UtiMax™has successfully completed a multicenter validation study and clinical testing. It does not require clinical isolates from urine cultures, enabling a rapid ID reporting in as short as 30 minutes and AST in 120 minutes for a positive ID result. - December 10, 2017 - GeneFluidics Inc.
VistaVu Solutions Acquires BPBD and Their SAP Business ByDesign Company
Acquisition continues to grow VistaVu Solutions’ Commitment to SAP Business ByDesign business segment. - December 07, 2017 - BPBD LLC
Making Artificial Intelligence Practical for Healthcare Marketers
Arteric Explains How to Uncover Hidden Marketing Insights. - December 06, 2017 - Arteric
RegenLab Issued New US Patent for Platelet Rich Plasma Kits
RegenLab is attempting to enforce its patent rights against Estar Technologies Ltd., manufacturer of the Eclipse PRP product, Eclipse Aesthetics LLC, a US distributor, as well as their customers. - December 05, 2017 - RegenLab
No Insight Left Behind. Guiding Healthcare Marketers to Wise Decisions About Artificial Intelligence.
Arteric Shares Its Practical Approach to Applying AI to Uncover Marketing Insights. - November 27, 2017 - Arteric
Creative BioMart to Expand Its Protein Glycosylation Labeling Service Capacity to Meet Rising Demands
Creative BioMart, a global leader in the supply of high quality protein products and efficient protein manufacturing techniques, today announced a major expansion of its Protein Glycosylation Labeling Service capacities as a response to rising customer needs and market demands for characterizing... - November 26, 2017 - Creative Biomart
Arteric Pushes Boundaries with Its New Corporate Website, Arteric.com
Healthcare Digital Marketing Agency Shares Strategic and Tactical Insights in a Future-Ready Experience - November 21, 2017 - Arteric
Stool Bank in Asia Welcomes New Scientist
The Asia Microbiota Bank, the first stool bank in Hong Kong, expands the team by adding a new scientist to help lead research efforts on bacteria clusters unique to the Asian population. The scientific team uses next generation sequencing and strain level analysis to optimize Fecal Microbiota Transplantation (FMT) treatment outcomes in Asia. "We hope that the deep FMT data we are collecting from around Asia will help uncover key strains that influence intestinal health."-Co-Founder, Jon Chan - November 16, 2017 - Asia Microbiota Bank
New Intelligence Tool Helps Researchers Cope with Immuno-Oncology Boom
Hanson Wade, the London-based life sciences knowledge services specialist, has launched IO Combination Trials Intelligence (www.beacon-intelligence.com), to provide clarity to pharma scientists and strategists in the booming immuno-oncology combination field of study. IO Combination Trials... - November 16, 2017 - Beacon Intelligence
Cellenkos Inc. Enters Regulatory T-Cell Platform Research Collaboration with MD Anderson
Cellenkos Inc. has announced a multi-year collaboration with The University of Texas MD Anderson Cancer Center focused on development of cord blood regulatory T cell (CB TREG) therapeutics for treatment of autoimmune disease and inflammatory disorders. As part of this collaboration, Cellenkos Inc. - November 15, 2017 - Cellenkos Inc.
Virun® NutraBIOsciences® Receives Certification for Production of Organic Products While Launching Natural Algal DHA MCT Multi-serving Smoothies
Virun® NutraBIOsciences® Prepares to Enter the Finished Product Market with Novel Flavors and Celebrates State Organic Certification. - November 14, 2017 - VIRUN
The European Medicines Agency Accepts Marketing Authorisation Application for Intrarosa for the Treatment of Vulvar and Vaginal Atrophy in Postmenopausal Women
Endoceutics Inc., a private Quebec City based biopharma company, today announced that the Committee for Medicinal Products for Human Use (CHMP) adopted a positive opinion, recommending the granting of a marketing authorisation for the medicinal product IntrarosaTM, intended for the treatment of... - November 13, 2017 - Endoceutics
A Practical Discussion About AI and Machine Learning in Healthcare Digital Marketing
Arteric’s President Prepares Healthcare Marketers to Transform Digital Disruption Into Competitive Advantage. - November 08, 2017 - Arteric
Virun® NutraBioSciences®, and Algarithm Ingredients Inc. to Lead Plant-Based Panel at SXSW Conference in 2018
Growing market demand for plant-based DHA omega-3 ingredients intersects with innovative food technology. - November 03, 2017 - VIRUN
BPBD, a Leading SAP Business ByDesign Provider, Expands Global Reach with German-Based all4cloud Partnership
BPBD adds all4cloud’s eam4cloud and scan4cloud to its new product offerings. - November 02, 2017 - BPBD LLC
MBF Therapeutics Inc. to Present at Philadelphia PACT Investor Conference
MBF Therapeutics, Inc., a clinical stage animal health company developing checkpoint inhibitor vaccines for cancer and infectious diseases, today announced that Thomas Tillett, Chief Executive Officer, will present at the PACT Capital Conference in Philadelphia, PA on Thursday, November 2, 2017 at... - November 01, 2017 - MBF Therapeutics Inc
Artificial Intelligence Accelerates Marketing: Biopharma and Medical Device eMarketing Summit
Digital Marketing Thought Leader Prepares Healthcare Marketers for the Next Digital Disruption - October 30, 2017 - Arteric
Clinerion Expands the Global Coverage of Its Services in the Americas, Adding 60 Million Patients in North America via Partnership with Provisio Inc.
Clinerion has expanded its geographic coverage to include over 60 million patients in the USA, via a strategic partnership with Provisio Inc. Clinerion now has a truly global footprint for its services for clinical trial patient search and identification, and data generation for real-world evidence and market access activities. - October 30, 2017 - Clinerion
NASA’s James Webb Space Telescope is Now Hanging Out in a Vibration-Isolating "Hammock" Supported by Minus K's Negative-Stiffness Vibration Isolators
NASA’s James Webb Space Telescope, the replacement to the Hubble Space Telescope is Now Hanging Out in a Vibration-Isolating "Hammock" Supported by Minus K's Negative-Stiffness Vibration Isolators in Johnson Space Center's Vaccum Chamber A being tested. - October 28, 2017 - Minus K Technology Inc.
Mercodia Releases Unique Multiplex Assay in Collaboration with Quansys
Multiplex assays have been plagued by a lack of specificity and accuracy, with unreliable data as a result. However, a new multiplex assay has reached the US market. Mercodia, based in Sweden, has teamed-up with Quansys Biosciences, based in the US, to launch the AKURIO Islet Hormones multiplex assay, which measures four of the most notable hormones in pancreatic research: glucagon, insulin, C‑peptide and proinsulin. - October 27, 2017 - Mercodia AB
Prosidyan Announces FDA Clearance and Commercial Launch of Its FIBERGRAFT BG MATRIX for Poster-Lateral Spinal Fusion
NJ-based Prosidyan (www.prosidyan.com), developer of proprietary fiber-based bioactive glass products, announced today FDA 510(k) clearance and full commercial launch of FIBERGRAFT BG Matrix – Bone Graft Substitute for Postero-lateral Spinal Fusion. FIBERGRAFT BG Matrix is the third... - October 26, 2017 - Prosidyan, Inc.
Batavia Biosciences Expands Its Viral Vector and GMP Facilities to Accommodate Increasing Market Demand
Today, Batavia Biosciences announces the expansion of its viral vector process development facilities in the USA and its GMP clean room facilities in the Netherlands to accommodate the increasing market demand. - October 18, 2017 - Batavia Biosciences
Qrons Inc. Announces Launch of New Website Website Offers Visitors Insight Into the Company's Innovative Multi-Disciplinary Approach to Traumatic Brain Injuries
Qrons Inc. (OTCPK: QRON) ("Qrons " or the "Company"), a preclinical biotechnology company developing advanced cell-based solutions to combat neuronal injuries with a laser focus on traumatic brain injuries, announced today the launch of its fully featured website. The website... - October 10, 2017 - Qrons Inc.
G&L Scientific Announces the Appointment of Richard Edmunds as Vice President, Regulatory Affairs
Global provider of Clinical & Regulatory Affairs consultancy services continues to attract top talent. - October 09, 2017 - G&L Scientific Inc
Digital Pharma East and Arteric Have Partnered to Lead Healthcare Marketing’s Digital Transformation
Digital Marketing Agency Continues Support of Major Healthcare Conference. - October 04, 2017 - Arteric
BPBD, a Leading SAP Business ByDesign Partner, Introduces New Pharmaceutical Manufacturing Add-On Solution for Business ByDesign
BPBD’s New Pharma Manufacturing Solution Add-On Enables Cloud-Based ERP Solution for Compliance Certification with FDA CFR 21 Part 11 and EU Annex 11 - October 04, 2017 - BPBD LLC
Wake Research Expands North American Presence to West Coast with Acquisition of Medical Center for Clinical Research – San Diego
Adds to Strategic Partnerships across Western and Southern United States - October 04, 2017 - Wake Research Associates
MappBio Announces Contracts with BARDA for ZMapp and Additional Filovirus Medical Countermeasures
Mapp Biopharmaceutical, Inc., announced today that it has been awarded a Project BioShield contract (HHSO100201700017C) of approximately $46 million by The Biomedical Advanced Research and Development Authority (BARDA), part of the Office of the Assistant Secretary for Preparedness and Response at... - September 30, 2017 - Mapp Biopharmaceutical, Inc.
AngioSoma, Inc. (OTC: SOAN) Announces Agreement with Esther & Esther, Inc. to Maximize Sales of Its OTC Products with Existing Online Marketing Platform
AngioSoma, Inc. (OTC: SOAN) announces Agreement with Esther & Esther, Inc. to maximize sales of its OTC products with existing online marketing platform. Conjunctionally, the company’s subsidiary, Soma Nutraceuticals Inc., completed a licensing agreement with Kentucky-based East Kentucky... - September 18, 2017 - AngioSoma, Inc.
Cayman Contributes Tandem Spectra Data to Cloud-Based Mass Spectral Library
Cayman Chemical is collaborating with ThermoFisher and HighChem to provide accurate and high quality tandem spectra to the mzCloud™ library of mass data. mzCloud™ is a web-based mass spectral database comprised of a curated collection of high- and low-resolution MSn spectra acquired... - September 16, 2017 - Cayman Chemical Company
AdvantaPure(R) Introduces AdvantaSil(TM) High Pressure Silicone Tubing; Ideal for TFF Systems, Integrity Testing, Purification Processes
AdvantaPure has launched AdvantaSil High Pressure unreinforced silicone tubing, a product designed to allow for biopharm and pharmaceutical fluid processing at higher flow rates. The tubing offers pressure usage three times that of standard silicone transfer tubing, along with benefits such as limited pumpability up to 30 psi back pressure, full vacuum capabilities on most sizes and better clarity than braided silicone hose. Full BPOG testing is in process. This product is made in USA. - September 15, 2017 - AdvantaPure
Drugshoppe Selected as Finalist for 2017 Innovation Conference and Showcase
Drugshoppe was selected as a finalist in the first annual pitch competition at the Houston Technology Center Innovation Conference and Showcase. Drugshoppe was picked from among many companies that applied in the fields of life sciences, aerospace, energy, IT, and transportation. Drugshoppe will... - September 14, 2017 - Drugshoppe
Source Intelligence Annual Analysis of Conflict Minerals Filings Show Companies Remain Concerned About Consumer-Facing Transparency
Source Intelligence has released its annual analysis of conflict minerals reports for the 2016 reporting year and despite U.S. government efforts to relax requirements, companies continue to demonstrate increased efforts to minimize sourcing from conflict regions. For direct access to the report,... - September 08, 2017 - Source Intelligence
Vascular BioSciences Awarded Up to $2.3 Million Fast-Track STTR Grant from NHLBI To Develop CAR Peptide for Pulmonary Hypertension
Project to be Conducted in Collaboration with Brigham and Women’s Hospital, Harvard Medical School. Vascular BioSciences announced today it has an award for a Phase I/II Fast-Track STTR grant in collaboration with Brigham and Women’s Hospital, Harvard Medical School. The STTR... - September 08, 2017 - Vascular BioSciences, Inc
Apostle Inc Appoints Director of Oncology Research at Stanford University to Scientific Advisory Board
Apostle Inc is pleased to announce the appointment of Dean W. Felsher, MD, PhD as a new member to its Scientific Advisory Board. Dr. Felsher is Professor of Medicine in Departments of Oncology and Pathology at Stanford University School of Medicine. He is Director of Stanford Translational Research... - September 01, 2017 - Apostle Inc